[{"indications": "Indications\u00a0(specialist use only) nephropathic cystinosis", "name": "MERCAPTAMINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "9 Nutrition and blood", "9.8 Metabolic disorders", "9.8.1 Drugs used in metabolic disorders", "Nephropathic cystinosis"], "cautions": "Cautions\u00a0leucocyte-cystine concentration and haematological\r\nmonitoring required\u2014consult product literature; dose of phosphate supplement may need to be adjusted if transferring\r\nfrom phosphocysteamine to mercaptamine", "side-effects": "Side-effects\u00a0breath and body odour, nausea, vomiting, diarrhoea,\r\nanorexia, abdominal pain, gastroenteritis, dyspepsia, encephalopathy,\r\nheadache, malaise, fever, rash; less commonly gastro-intestinal\r\nulcer, seizures, hallucinations, somnolence, nervousness, leucopenia,\r\nnephrotic syndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/73091.htm", "doses": ["Initial doses should be one-sixth to one-quarter of the\r\nexpected maintenance dose, increased gradually over 4\u20136 weeks ", "Maintenance, adult and child over 50\u00a0kg body-weight,\r\n2\u00a0g daily in 4 divided doses", "child up to 12 years, 1.3\u00a0g/m2 (approx. 50\u00a0mg/kg) daily in 4 divided doses"], "pregnancy": "Pregnancy\u00a0avoid\u2014teratogenic and toxic in animal studies"}]